| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||
| Coenzyme Q10 (CoQ10), also known as ubiquinone, is a fat-soluble antioxidant and a critical component of the mitochondrial electron transport chain, essential for ATP production. Its potential role in Alzheimer’s disease (AD) and cancer has been increasingly studied, mainly due to its effects on oxidative stress, mitochondrial function, and cellular energy metabolism. Two types: ubiquinone(standard) vs ubiquinol(more bioavailable) -high content in beef heart -Acts as an antioxidant, reducing ROS -Some preclinical studies suggest CoQ10 may reduce Aβ-induced neurotoxicity -CoQ10 is sometimes used with chemotherapy to reduce cardiotoxicity (especially with doxorubicin). -Essential for ATP (energy) production. -CoQ10 levels may drop by 25–40% in people taking statins. -May support mitochondrial function in neurodegenerative diseases, including Alzheimer’s and Parkinson’s Coenzyme Q10 exists in three redox states: Form Name Abbreviation Redox state Oxidized Ubiquinone CoQ10 Oxidized (labeled “Coenzyme Q10”, “CoQ10”) Semiquinone Ubiquinol radical CoQ10•– Intermediate (labeled “Ubiquinol”, “Reduced CoQ10”) Reduced Ubiquinol CoQ10H₂ Reduced Most supplements = ubiquinol (reduced, antioxidant) Ubiquinol is often preferred for cardiovascular, aging, and antioxidant-focused use. BPM31510 = ubiquinone (oxidized) (might raise ROS in cancer cells) >80–95% of circulating CoQ10 is ubiquinol, regardless of whether ubiquinone or ubiquinol was ingested -CoQ10 is fat-soluble, so take it alongside meals that include nutrient-dense fats like coconut oil, butter or tallow in moderation -initial 200-300mg/day (split during day) down to 100mg after 21 days BPM31510: Pharmaceutical oxidized CoQ10 BPM31510 = oxidized CoQ10 (ubiquinone) in a specialized lipid formulation. BPM31510 increases Mitochondrial ROS in cancer cells. That increase is intentional, central to its mechanism, and relatively selective for tumor cells. BPM31510 Studies report in cancer cells: ↑ mitochondrial ROS ↑ lipid peroxidation ↓ NADPH/NADP⁺ ratio ↓ GSH/GSSG ratio Activation of oxidative stress pathways Cell death without classic antioxidant rescue Importantly: Trolox, NAC, or GSH can partially blunt BPM31510 effects, confirming ROS dependence Coenzyme Q10 (CoQ10 / Ubiquinone) — Cancer vs Normal Cell Effects
|
| Source: |
| Type: |
| Cytochrome c ** The term "release of cytochrome c" ** an increase in level for the cytosol. Small hemeprotein found loosely associated with the inner membrane of the mitochondrion where it plays a critical role in cellular respiration. Cytochrome c is highly water-soluble, unlike other cytochromes. It is capable of undergoing oxidation and reduction as its iron atom converts between the ferrous and ferric forms, but does not bind oxygen. It also plays a major role in cell apoptosis. The term "release of cytochrome c" refers to a critical step in the process of programmed cell death, also known as apoptosis. In its new location—the cytosol—cytochrome c participates in the apoptotic signaling pathway by helping to form the apoptosome, which activates caspases that execute cell death. Cytochrome c is a small protein normally located in the mitochondrial intermembrane space. Its primary role in healthy cells is to participate in the electron transport chain, a process that helps produce energy (ATP) through oxidative phosphorylation. Mitochondrial outer membrane permeability leads to the release of cytochrome c from the mitochondria into the cytosol. The release of cytochrome c is a pivotal event in apoptosis where cytochrome c moves from the mitochondria to the cytosol, initiating a chain reaction that leads to programmed cell death. On the one hand, cytochrome c can promote cancer cell survival and proliferation by regulating the activity of various signaling pathways, such as the PI3K/AKT pathway. This can lead to increased cell growth and resistance to apoptosis, which are hallmarks of cancer. On the other hand, cytochrome c can also induce apoptosis in cancer cells by interacting with other proteins, such as Apaf-1 and caspase-9. This can lead to the activation of the intrinsic apoptotic pathway, which can result in the death of cancer cells. Overexpressed in Breast, Lung, Colon, and Prostrate. Underexpressed in Ovarian, and Pancreatic. |
| - | in-vitro, | CRC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:356 Target#:77 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid